$0.2512
At close: Apr 21, 2:49 PM EDT
Comments
Loading...
Venus Medtech (Hangzhou) Analyst Ratings and Price Targets | OTC:VMTHF | Benzinga
Venus Medtech (Hangzhou) Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Venus Medtech (Hangzhou) Corp from these most-recent analyst ratings.
Analyst Ratings for Venus Medtech (Hangzhou)
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Venus Medtech (Hangzhou) (VMTHF) stock?
There is no price target for Venus Medtech (Hangzhou)
What is the most recent analyst rating for Venus Medtech (Hangzhou) (VMTHF)?
There is no analyst for Venus Medtech (Hangzhou)
When was the last upgrade for Venus Medtech (Hangzhou) (VMTHF)?
There is no last upgrade for Venus Medtech (Hangzhou)
When was the last downgrade for Venus Medtech (Hangzhou) (VMTHF)?
There is no last downgrade for Venus Medtech (Hangzhou).
When is the next analyst rating going to be posted or updated for Venus Medtech (Hangzhou) (VMTHF)?
There is no next analyst rating for Venus Medtech (Hangzhou).
Is the Analyst Rating Venus Medtech (Hangzhou) (VMTHF) correct?
There is no next analyst rating for Venus Medtech (Hangzhou).
Browse analyst ratings and price targets on all stocks.
